Delfortgroup AG
USPTO PatentsView assignee record - 24 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw).
The verdict
According to USPTO PatentsView, Delfortgroup ranks #12,407 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 12 technology areas.
- #12,407
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (40.9/100)
- 25.4
- avg claims per patent
- -71%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12407 · Foreign Corporation #12,407 · 24 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 24 grants
- UPPER-Q #12,407/49,997
- PHOTO-FINISH Cyclerion Therapeutics
- CPC-FOCUS D21H · 12 areas
- INNOV-PAR 40.9/100
- CLAIMS-DENSE 25.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -71% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cyclerion Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Delfortgroup’s 40.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Delfortgroup
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Delfortgroup · this assignee
Delfortgroup · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Delfortgroup's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Delfortgroup?
Each dot is one of Delfortgroup’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Delfortgroup’s own 25.4 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Delfortgroup's grants concentrate
Delfortgroup AG is a focused PatentsView assignee: 12 CPC subclasses with 75% of grants classified under D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2018. By volume, Delfortgroup sits between Cyclerion Therapeutics, Inc. and Digitalinsights Inc..
Delfortgroup's three-year grant acceleration
Delfortgroup AG shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Delfortgroup's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cyclerion Therape…
Cyclerion Therapeutics, Inc.
24 patents
- Cyral
Cyral Inc.
24 patents
- D-link
D-Link Corporation
24 patents
- Deka Biosciences
Deka Biosciences, Inc.
24 patents
- Denka Seiken
Denka Seiken Co., Ltd.
24 patents
- Dentsu
Dentsu Inc.
24 patents
- Digital Surgery
Digital Surgery Limited
24 patents
- Digitalinsights
Digitalinsights Inc.
24 patents
- Delfortgroup ◀
Delfortgroup AG
24 patents
What this shows Delfortgroup holds 24 patents at rank #12,403, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Delfortgroup
By rank, the assignees closest to #12,403 in granted patent volume.
- Cyclerion Therapeutics, Inc. #12,399 · 24 patents
- Cyral Inc. #12,400 · 24 patents
- D-Link Corporation #12,401 · 24 patents
- Deka Biosciences, Inc. #12,402 · 24 patents
- Denka Seiken Co., Ltd. #12,404 · 24 patents
- Dentsu Inc. #12,405 · 24 patents
- Digital Surgery Limited #12,406 · 24 patents
- Digitalinsights Inc. #12,407 · 24 patents
Leaders in D21H (Pulp Compositions)
Other assignees with the most granted patents in Delfortgroup's primary technology class.
Delfortgroup's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 8.3% |
| 2016 | 6 | 25.0% |
| 2017 | 2 | 8.3% |
| 2018 | 1 | 4.2% |
| 2019 | 6 | 25.0% |
| 2020 | 1 | 4.2% |
| 2021 | 1 | 4.2% |
| 2022 | 1 | 4.2% |
| 2024 | 2 | 8.3% |
| 2025partial year | 2 | 8.3% |
Which technologies does Delfortgroup AG patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Delfortgroup AG's patent record in context - here's where to go next.
- Delfortgroup AG's lead technology class is D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw), 75% of its portfolio - see every assignee active in that class. Explore D21H
- Ranked #12,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Delfortgroup AG against Cyclerion Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.